Database Query Results : Galantamine, ,
Gala, Galantamine: Click to Expand ⟱
| Features: |
Galantamine
FDA approved drug for mild to moderate Alzheimer's Disease
- AChE inhibitor (reversible, competitive)
-May improve memory, cognition, and behavior
|
Scientific Papers found: Click to Expand⟱
*AChE↓, *Inflam↓, *Aβ↓, *cognitive↑, *ROS↓,
*AChE↓, *MDA↑, *GSH↑, *BBB↑,
*BChE↓, *AChE↓, *Ach↑, *cognitive↑, *memory↑, *ROS↓, *Inflam↓, *NF-kB↓, *COX2?,
*BDNF↑, *cognitive↑,
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Total Targets: 0
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
GSH↑, 1, MDA↑, 1, ROS↓, 2,
Transcription & Epigenetics ⓘ
Ach↑, 1,
Barriers & Transport ⓘ
BBB↑, 1,
Immune & Inflammatory Signaling ⓘ
COX2?, 1, Inflam↓, 2, NF-kB↓, 1,
Synaptic & Neurotransmission ⓘ
AChE↓, 3, BChE↓, 1, BDNF↑, 1,
Protein Aggregation ⓘ
Aβ↓, 1,
Functional Outcomes ⓘ
cognitive↑, 3, memory↑, 1,
Total Targets: 14
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:344 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid
Home Page